BioLight Life Sciences Ltd. (TLV:BOLT)

BioLight Life Sciences Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 19, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	33	25	24	30	53	34
Market Cap Growth	73.53%	4.99%	-19.99%	-42.70%	53.43%	-9.45%
Enterprise Value	12	13	12	5	12	-16
Last Close Price	3.68	5.44	5.20	6.61	11.54	7.55
PE Ratio	-	-	-	-	137.74	-
PS Ratio	1584.62	115.64	204.41	478.54	17539.14	1106.27
PB Ratio	0.82	0.82	0.80	0.56	0.86	0.57
P/TBV Ratio	0.90	0.97	0.83	0.57	0.87	0.58
EV/Sales Ratio	-	58.93	104.02	86.87	4057.47	-
Debt / Equity Ratio	0.01	0.02	0.00	0.01	0.01	0.02
Asset Turnover	-	0.01	0.00	0.00	0	0
Quick Ratio	19.08	6.52	3.73	6.95	15.25	19.99
Current Ratio	19.08	6.94	3.91	7.11	15.38	20.09
Return on Equity (ROE)	-	-27.60%	-65.45%	-15.09%	-0.56%	-22.10%
Return on Assets (ROA)	-	-18.71%	-14.72%	-10.65%	-10.27%	-10.19%
Return on Capital (ROIC)	-	-20.48%	-15.73%	-11.12%	-10.78%	-10.99%
Return on Capital Employed (ROCE)	-31.80%	-31.60%	-34.20%	-18.90%	-17.10%	-18.30%
Earnings Yield	-42.22%	-28.20%	-107.88%	-26.03%	0.73%	-39.02%
FCF Yield	-	-43.52%	-45.57%	-31.75%	-20.20%	-39.35%
Buyback Yield / Dilution	-3.47%	-0.29%	-1.70%	0.41%	-0.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.